ghk-cu administration subcutaneous Dosage and Protocol: A Medical Provider's Guide to the 30-Day Cycle ghk-cu administration subcutaneous #creatorsearchinsights ghk
Description
Antibodies against phospho-ERK1/2 (#4370), total ERK1/2 (#4695), phospho-p38 MAPK (#4511), total p38 MAPK (#9212), phospho-JNK1/2 (#4668), total JNK1/2 (#9252), phospho-NF-B p65 (Ser536, #3033) and -actin (#3700) were purchased from Cell Signaling (MA, USA)
Day and Time: The specific day of administration and, if necessary, the timing for numerous injections
Dosing frequencyvaries depending on research protocol, but is often used daily or every other day
Ill be straight with you, though
Color changes indicate problems
